Evidence map›Paper›PMID 20126551›Full record

ArticlePloS one2010

Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.

Victoria E Abraira, Takunori Satoh, Donna M Fekete, Lisa V Goodrich

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. QTL Mapping of Endocochlear Potential Differences between C57BL/6J and BALB/cJ mice.Journal of the Association for Research in Otolaryngology : JARO · 2016
    Article
  9. Article
  10. LRIG and cancer prognosis.Acta oncologica (Stockholm, Sweden) · 2014
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Conditional gene expression in the mouse inner ear using Cre-loxP.Journal of the Association for Research in Otolaryngology : JARO · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Victoria E AbrairaDepartment of Neurobiology and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts, United States of America.
Takunori Satoh
Donna M Fekete
Lisa V Goodrich
Harvard University · USNagoya University · JPPurdue University West Lafayette · US

Funding

DEVELOPMENT STUDIES OF THE INNER EARR01DC002756 · NIDCD · PURDUE UNIVERSITY WEST LAFAYETTE · PI FEKETE, DONNA M · 1995 to 2019
$6.8M
Cellular and Molecular Mechanisms of Ear MorphogenesisR01DC007195 · NIDCD · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GOODRICH, LISA · 2005 to 2014
$4.0M
Lrig interactions with ErbB pathways in the inner earF31DC008450 · NIDCD · HARVARD MEDICAL SCHOOL · PI ABRAIRA, VICTORIA EUGENIA GUADALUPE · 2006 to 2008
$86k
NIDCD NIH HHS F31 DC008450NIDCD NIH HHS R01 DC002756NIDCD NIH HHS R01 DC007195
6 · The paper itself

Abstract

backgroundThe Lrig genes encode a family of transmembrane proteins that have been implicated in tumorigenesis, psoriasis, neural crest development, and complex tissue morphogenesis. Whether these diverse phenotypes reflect a single underlying cellular mechanism is not known. However, Lrig proteins contain evolutionarily conserved ectodomains harboring both leucine-rich repeats and immunoglobulin domains, suggesting an ability to bind to common partners. Previous studies revealed that Lrig1 binds to and inhibits members of the ErbB family of receptor tyrosine kinases by inducing receptor internalization and degradation. In addition, other receptor tyrosine kinase binding partners have been identified for both Lrig1 and Lrig3, leaving open the question of whether defective ErbB signaling is responsible for the observed mouse phenotypes. METHODOLOGY/PRINCIPAL

findingsHere, we report that Lrig3, like Lrig1, is able to interact with ErbB receptors in vitro. We examined the in vivo significance of these interactions in the inner ear, where Lrig3 controls semicircular canal formation by determining the timing and extent of Netrin1 expression in the otic vesicle epithelium. We find that ErbB2 and ErbB3 are present in the early otic epithelium, and that Lrig3 acts cell-autonomously here, as would be predicted if Lrig3 regulates ErbB2/B3 activity. However, inhibition of ErbB activation in the chick otic vesicle has no detectable effect on Netrin gene expression or canal morphogenesis. CONCLUSIONS/SIGNIFICANCE: Our results suggest that although both Lrig1 and Lrig3 can interact with ErbB receptors in vitro, modulation of Neuregulin signaling is unlikely to contribute to Lrig3-dependent processes of inner ear morphogenesis. These results highlight the similar binding properties of Lrig1 and Lrig3 and underscore the need to determine how these two family members bind to and regulate different receptors to affect diverse aspects of cell behavior in vivo.

Indexed as

MorphogenesisAnimalsBlotting, WesternCell LineChick EmbryoEar, InnerEpitheliumFemaleGene Expression Regulation, DevelopmentalHumansIn Situ HybridizationMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutLrig3 protein, mouseMembrane ProteinsNerve Growth FactorsNetrin-1NeuregulinsNTN1 protein, humanReceptor, ErbB-3Tumor Suppressor Proteins

Identifiers

PMID20126551
PMCPMC2813878
OpenAlexW2062960717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.